The present invention relates to a sponge dressing for treating wounds comprised of a polymer sponge containing a plurality of antimicrobial dyes with at least one dye being gram positive and at least one other dye being gram negative and a silicon adhesive secured to a sponge surface. The sponge dressing can be exposed initially to gamma radiation and later sterilized by ethylene oxide or alternatively it can be sterilized by ethylene oxide and later irradiated by gamma radiation. The sponge dressing has a morphology characterized by an average pore throat diameter of 0.5-500 m and a porosity ranging from about 60% to about 99.5%. The sponge dressing can also contain at least one biofilm reducing agent, at least one chelating agent and an ionic and non-ionic surfactant.

A pump-type bottle configured to discharge a disinfectant for hands and fingers is disposed at a wall portion in the aircraft cabin via an arrangement instrument at a height at which a passenger can push down a head portion thereof.

Disclosed is a cap configured for removable attachment a medical device. The cap has a body with an opening, a bottom, and a chamber defined between the opening and the bottom. The cap has a wall of the chamber comprising a thread originating proximate the opening and extending into the chamber by a height. The height of the thread increases as a function of increasing distance from the opening. A liquid disinfectant is contained within the chamber.

Methods and apparatus for sterilizing plant material include disposing plant material in a sub-atmospheric pressure environment, dispersing a non-toxic, non-polymerizable gas into the sub-atmospheric pressure environment, applying an electric field to change the gas into cold plasma, and maintaining exposure of the plant material to the cold plasma until substantially sterilized plant material is obtained, wherein an amount of at least one active constituent in the plant material is substantially unchanged by the sterilizing. The plant material may be cannabis.

A drug delivery device that includes a body storing a VEGF antagonist, a plunger rod contacting a stopper inside the body, and a flange coupled to the body. The body is silicone-free. The plunger rod includes protrusions and the flange includes a proximal collar and slots positioned along the proximal collar. The flange is configured such that when the protrusions and slots are misaligned, distal movement of the plunger rod relative to the body is limited upon the protrusions contacting the proximal collar to prime the drug delivery device. The flange is configured such that when the protrusions and slots are aligned, distal movement of the plunger rod relative to the body is limited upon the protrusions extending into the slots to deliver the VEGF antagonist.

The present invention relates to a device for applying medical and cosmetic radiation to a human body or to parts thereof. Said radiation is preferably optical radiation. The device according to the invention comprises at least one first illuminant for producing the medical and cosmetic radiation. The device also comprises a first air flow for cooling an illuminant and a second air flow for cooling the human body or parts thereof. The device comprises at least one air-conditioning system, which is fluidically connected to the second air flow and designed for the air-conditioning treatment of the air flow. The device is characterized in that the device also has at least one disinfecting chamber, which is fluidically connected to the second air flow and is designed to physically disinfect the second air flow. The invention also relates to a method for operating such a device and to a corresponding disinfecting chamber.

The present technology relates to a novel sanitization method for chromatography media and supporting equipment comprising treatment with a sanitization/sterilization solution comprising acetic acid and hexylene glycol.

In one aspect, an implantable medical device comprising: a germicidal irradiation source comprising an ultraviolet germicidal irradiation (UVGI) light source, wherein the germicidal irradiation source is on an exterior surface of a portion of implantable medical device, and wherein the UVGI light source is configured to emits a UVGI light to kill or inactivate microorganisms; an implantable power generator comprising a power source configured to provide power to the implantable medical device and the germicidal irradiation source.

The disclosure relates to organosulfur compounds and compositions comprising same. In particular, the disclosure relates to Bis(4-fluorophenyl) disulfide, Bis(4-chlorophenyl) disulfide, Bis(4-chlorophenyl) thiosulfinate, Bis(4-fluorophenyl) thiosulfinate, Bis(4-chlorophenyl) thiosulfonate, Bis(4-fluorophenyl) thiosulfonate, and Di-isopropyl thiosulfonate. Such compositions are useful for treating microbial infection, in particular bacterial, fungal, rotozoan or algal infection. Compositions comprising said compounds are also provided for cleaning, disinfecting or agricultural use.

A sterilization system for sterilizing an article may include a hydroxyl generation system configured to generate a first flow of hydroxyl ions and a gas transport system configured to transport the first flow of hydroxyl ions to the article and expose the article to the first flow of hydroxyl ions to sterilize the article.